Fluvoxamine-induced neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is an uncommon but life-threatening idiosyncratic drug reaction that occurs following neuroleptic drug exposure. The estimated incidence of NMS is though very low, resulting mortality rates range between 4% and 30%. There is increasing evidence that “Atypical” an...

Full description

Bibliographic Details
Published in:Journal of the Scientific Society
Main Authors: Adarsh Bellad, Vinayak Koparde, Sandeep Patil, Sameeran Chate
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Subjects:
Adverse drug reactions
fluvoxamine
neuroleptic malignant syndrome
SSRIs
Online Access:http://www.jscisociety.com/article.asp?issn=0974-5009;year=2017;volume=44;issue=3;spage=161;epage=162;aulast=Bellad

Internet

http://www.jscisociety.com/article.asp?issn=0974-5009;year=2017;volume=44;issue=3;spage=161;epage=162;aulast=Bellad

Similar Items